Collectively, these results demonstrate that downregulated PTPN13 expression is significantly associated with poor prognoses in HCC patients and strongly suggest that PTPN13 may have a substantial effect on HCC malignancy. This evidence concerns the gene PTPN13 and hepatocellular carcinoma.